Johnson & Johnson EPS (Earnings per Share) 2007–2025
Johnson & Johnson reported $11.03 of earnings per share for fiscal 2025. That was 90.5% higher than fiscal 2024. Compared with fiscal 2019, the change was +95.9%.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $11.03 | +90.5% |
| FY 2024 | $5.79 | -57.8% |
| FY 2023 | $13.72 | +103.9% |
| FY 2022 | $6.73 | -13.8% |
| FY 2022 | $7.81 | +41.7% |
| FY 2021 | $5.51 | -2.1% |
| FY 2019 | $5.63 | +0.4% |
| FY 2018 | $5.61 | +1093.6% |
| FY 2017 | $0.47 | -92.1% |
| FY 2017 | $5.93 | +8.2% |
| FY 2016 | $5.48 | -3.9% |
| FY 2014 | $5.70 | +18.5% |
| FY 2013 | $4.81 | +24.6% |
| FY 2012 | $3.86 | +10.6% |
| FY 2012 | $3.49 | -27.0% |
| FY 2011 | $4.78 | +8.6% |
| FY 2010 | $4.40 | -3.7% |
| FY 2008 | $4.57 | +25.9% |
| FY 2007 | $3.63 | — |
Source: Johnson & Johnson SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open JNJ 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Johnson & Johnson reported $11.03 of earnings per share for fiscal 2025. That was 90.5% higher than fiscal 2024. Compared with fiscal 2019, the change was +95.9%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Johnson & Johnson
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeJohnson & Johnson — frequently asked questions
What is Johnson & Johnson's earnings per share?
Johnson & Johnson (JNJ) reported earnings per share of $11.03 for fiscal year 2025, per its SEC filings.
How has Johnson & Johnson's earnings per share changed over time?
Between fiscal 2007 and 2025, JNJ's earnings per share grew at roughly 6.4% per year (compound annual rate), from $3.63 to $11.03.
Where does this data come from?
Figures are computed from Johnson & Johnson's official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.